Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleIRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients.AuthorsPalmieri, Carlo; Stein, Rob; Liu, Xinxue; Hudson, Emma; Nicholas, Hanna; Sasano, Hironobu; Guestini, Fouzia; Holcombe, Chris; Barrett, Sophie; Kenny, Laura; Reed, Sadie; Lim, Adrian; Hayward, Larry; Howell, Sacha; Coombes, R.PublicationBreast Cancer Research & Treatment, 2017, Vol 165, Issue 2, p343ISSN0167-6806Publication typeArticleDOI10.1007/s10549-017-4328-z